Sutro Biopharma Inc. (NASDAQ: STRO)
$4.20
-0.0250 ( -0.59% ) 668.2K
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Market Data
Open
$4.20
Previous close
$4.22
Volume
668.2K
Market cap
$343.13M
Day range
$4.00 - $4.35
52 week range
$2.01 - $6.13
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 04, 2024 |
8-k | 8K-related | 17 | Feb 09, 2024 |
4 | Insider transactions | 1 | Jan 31, 2024 |
4 | Insider transactions | 1 | Jan 31, 2024 |
4 | Insider transactions | 1 | Jan 31, 2024 |
4 | Insider transactions | 1 | Jan 31, 2024 |
8-k | 8K-related | 42 | Jan 08, 2024 |
4 | Insider transactions | 1 | Dec 04, 2023 |
8-k | 8K-related | 12 | Nov 27, 2023 |
8-k | 8K-related | 14 | Nov 21, 2023 |